PMID: 7952861Aug 1, 1994

Antiarrhythmic effects of BN-063, a newly synthesized adenosine A1 agonist, on myocardial ischaemia in rats

British Journal of Pharmacology
Y M LeeM H Yen


1. It has been shown that adenosine is able to reduce the severity of arrhythmias induced by myocardial ischaemia. In isolated preparations, the antiarrhythmic effect of adenosine on ventricular myocardium is known to antagonize the catecholamine-induced stimulation of intracellular cyclic AMP production, an effect mediated via adenosine A1 receptors. 2. The aim of this study was to evaluate the antiarrhythmic effect of BN-063 (1-cyclopropylisoguanosine), a newly synthesized selective adenosine A1 agonist, on ventricular arrhythmias in rats. 3. Arrhythmias were induced by left coronary artery ligation or by administration of isoprenaline (7 mg kg-1) subcutaneously. Pretreatment with BN-063 (0.25, 0.5 and 1.0 mg kg-1) 10 min prior to occlusion significantly delayed the onset of ventricular arrhythmias, reduced the total number of ventricular premature contraction (VPC) and ventricular tachycardia (VT), decreased the incidence of VT and ventricular fibrillation (VF) and mortality during the first 30 min following left coronary artery ligation. In contrast, pretreatment with 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), an adenosine A1 antagonist, was arrhythmogenic during the ischaemic period. The rate-pressure product, an index fo...Continue Reading


May 1, 1992·Cardiovascular Research·A VeghJ R Parratt
Feb 7, 1992·Journal of Medicinal Chemistry·K A JacobsonM Williams
May 1, 1991·Circulation·B B Lerman, L Belardinelli
Jan 1, 1985·Journal of Cardiovascular Pharmacology·T AbrahamssonL Carlsson
Jan 1, 1985·Journal of Cardiovascular Pharmacology·A Zaza, P J Schwartz
Jan 12, 1988·European Journal of Pharmacology·C L Wainwright, J R Parratt
Apr 20, 1984·European Journal of Pharmacology·O Fagbemi, J R Parratt
Sep 1, 1983·Circulation Research·L Belardinelli, G Isenberg
Oct 19, 1993·European Journal of Pharmacology·P L TaoJ W Chern
Jun 1, 1993·British Journal of Pharmacology·C L WainwrightH Van Belle
Jan 1, 1993·Cardiovascular Research·J M DowneyJ D Thornton
Jan 1, 1993·Cardiovascular Research·A Pelleg, L Belardinelli


May 24, 2014·Journal of Cardiovascular Pharmacology and Therapeutics·Ersöz Gonca, Faruk Darıcı

Related Concepts

BN 063
Cardiac Depressants
Cardiac Arrhythmia
Potassium Channel
Myocardial Ischemia
Rats, Holtzman
Purinergic P1 Receptor Agonists

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.